European Commission Urges EMA to Speed Up Biotech Act Preparations

The European Commission has called for the European Medicines Agency (EMA) to urgently advance preparations for the Biotech Act, which will impact clinical trials regulation and the Clinical Trials Information System (CTIS).

Why it matters. The changes will affect clinical trials and the CTIS, impacting about 70% of its current functionality.